UCSF Awarded $67.5 Million to Develop New Antiviral Therapies

Scientists at UCSF QBI and the QBI Coronavirus Research Group (QCRG) have been awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness.